Side-by-side comparison of AI visibility scores, market position, and capabilities
Bethesda largest defense contractor (NYSE: LMT) ~$71B FY2024 revenue; F-35 $12.5B contract (Lots 18-19, ~300 fighters Sept 2025), Sikorsky Black Hawk, 122,000 employees competing with RTX and Northrop Grumman.
Lockheed Martin Corporation is a Bethesda, Maryland-based global aerospace, defense, security, and advanced technologies company — publicly traded on the New York Stock Exchange (NYSE: LMT) as an S&P 500 Industrials component — designing, developing, manufacturing, and sustaining advanced technology systems and services for the US government, US allies, and international defense customers through approximately 122,000 employees worldwide. Lockheed Martin is the world's largest defense contractor by revenue, generating approximately $71 billion in fiscal year 2024 revenue primarily from the US Department of Defense. The company's flagship program — the F-35 Lightning II stealth multirole fighter — is the costliest weapons program in US history, with total program lifetime cost exceeding $1.7 trillion through the 2070s. In September 2025, the Pentagon awarded Lockheed Martin a finalized $12.5 billion contract definitizing 148 F-35 Joint Strike Fighters from Lot 18 and adding scope for 148 additional fighters in Lot 19 — building on the initial $11.8 billion contract from December 2024 — continuing the F-35's multi-decade production run for US Air Force (F-35A), US Navy (F-35C), and US Marine Corps (F-35B STOVL) along with 8 international partner nations and 3 Foreign Military Sales customers. CEO Jim Taiclet leads Lockheed's digital transformation strategy — "21st Century Security" — integrating artificial intelligence, autonomous systems, advanced manufacturing, and network-centric warfare capabilities across Lockheed's platforms.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.